Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
Aim: To investigate the role of hepcidin (Hepc) in the formation of cells malignant phenotype in vitro and its expression in the dyna mics of growth of Walker-256 carcinosarcoma with different sensitivity to doxorubicin (Dox). Materials and Methods: The cell lines used in the analysis included T47D,...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2016 |
| Main Authors: | Yalovenko, T.M., Todor, I.M., Lukianova, N.Y., Chekhun, V.F. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2016
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/137998 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs / T.M. Yalovenko, I.M. Todor, N.Y. Lukianova, V.F. Chekhun // Experimental Oncology. — 2016 — Т. 38, № 2. — С. 84–88. — Бібліогр.: 35 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Features of hepcidin expression in patients with breast cancer
by: Yu. Lukianova, et al.
Published: (2015)
by: Yu. Lukianova, et al.
Published: (2015)
Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics
by: V. F. Chekhun, et al.
Published: (2016)
by: V. F. Chekhun, et al.
Published: (2016)
Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016)
by: Lukianova, N.Yu., et al.
Published: (2016)
Influence of ferromagnetic nanocomposite (Ferroplat) on human breast cancer cells of different malignancy degrees: pro/antioxidant balance and energy metabolism
by: Chekhun, V.F., et al.
Published: (2018)
by: Chekhun, V.F., et al.
Published: (2018)
Modifying effects of 5-azacytidine on metal-containing proteins profile in guerin carcinoma with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023)
by: Lukianova, N.Yu., et al.
Published: (2023)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: Chekhun, S.V., et al.
Published: (2014)
by: Chekhun, S.V., et al.
Published: (2014)
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)
by: Todor, I.N., et al.
Published: (2012)
Visualization of iron nanoparticles accumulation and distribution features in sensitive and resistant to antitumor drugs human breast cancer cells after different time intervals of cultivation with liposomal ferromagnetic
by: L. A. Nalieskina, et al.
Published: (2011)
by: L. A. Nalieskina, et al.
Published: (2011)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: S. V. Chekhun, et al.
Published: (2014)
by: S. V. Chekhun, et al.
Published: (2014)
Prognostic molecular-biological markers of malignant fibrous histiocytoma
by: O. O. Lytvynenko, et al.
Published: (2019)
by: O. O. Lytvynenko, et al.
Published: (2019)
Fractal dimension of the breast cancer cells resistant and sensitive to doxorubicin activity
by: Medviediev, O., et al.
Published: (2016)
by: Medviediev, O., et al.
Published: (2016)
Remodulating effect of doxorubicin on the state of iron-containing proteins, and redox characteristics of tumor with allowance for its sensitivity to cytostatic agents
by: V. F. Chekhun, et al.
Published: (2016)
by: V. F. Chekhun, et al.
Published: (2016)
Effect of anticancer drugs on breast cancer cells sensitive and resistant to doxorubicin: expression of mRNAs of TGF-β and its receptors
by: Chorna, I.V., et al.
Published: (2014)
by: Chorna, I.V., et al.
Published: (2014)
Effect of anticancer drugs on breast cancer cells sensitive and resistant to doxorubicin: expression of mRNAs of TGF-β and its receptors
by: I. V. Chorna, et al.
Published: (2014)
by: I. V. Chorna, et al.
Published: (2014)
The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: Vtorushin, S.V., et al.
Published: (2014)
by: Vtorushin, S.V., et al.
Published: (2014)
The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: S. V. Vtorushin, et al.
Published: (2014)
by: S. V. Vtorushin, et al.
Published: (2014)
B. subtilis mutants with the human Alu-repeat possess increased sensitivity to the cytostatic action of lektins
by: I. S. Karpova, et al.
Published: (2017)
by: I. S. Karpova, et al.
Published: (2017)
Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: Chekhun, V.F., et al.
Published: (2015)
by: Chekhun, V.F., et al.
Published: (2015)
Dihydropyrimidine dehydrogenase activity correlates with fluorouracil sensitivity in breast cancer
by: Yu, Z., et al.
Published: (2007)
by: Yu, Z., et al.
Published: (2007)
SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: S. V. Chekhun, et al.
Published: (2015)
by: S. V. Chekhun, et al.
Published: (2015)
Influence of exogenous lactoferrin on the oxidant/ antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro
by: Zalutski, I.V., et al.
Published: (2017)
by: Zalutski, I.V., et al.
Published: (2017)
Features of architectonics of neoplasms and molecular profile of tumor cells in patients with breast cancer
by: L. A. Nalieskina, et al.
Published: (2018)
by: L. A. Nalieskina, et al.
Published: (2018)
СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: Chekhun, S.V., et al.
Published: (2015)
by: Chekhun, S.V., et al.
Published: (2015)
Molecular-genetic bases of clinical heterogeneity of breast cancer (literature review)
by: L. A. Nalieskina, et al.
Published: (2017)
by: L. A. Nalieskina, et al.
Published: (2017)
Choosing chemotherapeutic treatment using the sensitivity markers in patients with colorectal cancer
by: M. V. Gljanko, et al.
Published: (2017)
by: M. V. Gljanko, et al.
Published: (2017)
Association of circulating miR-21, -205, and -182 with response of luminal breast cancers to neoadjuvant FAC and AC treatment
by: Chekhun, V.F., et al.
Published: (2023)
by: Chekhun, V.F., et al.
Published: (2023)
The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome
by: Timovska, Yu., et al.
Published: (2011)
by: Timovska, Yu., et al.
Published: (2011)
Chemocine receptor CXCR4 expression and microvessels density in malignant tumors of the breast of patients with sings of metabolic syndrome
by: N. P. Yurchenko, et al.
Published: (2020)
by: N. P. Yurchenko, et al.
Published: (2020)
Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: V. F. Chekhun, et al.
Published: (2015)
by: V. F. Chekhun, et al.
Published: (2015)
The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
by: Yu. Lukianova, et al.
Published: (2017)
by: Yu. Lukianova, et al.
Published: (2017)
Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
by: Naleskina, L.A., et al.
Published: (2016)
by: Naleskina, L.A., et al.
Published: (2016)
Clinical significance of hormonal receptor status of malignant ovarian tumors
by: Tkalia, I.G., et al.
Published: (2014)
by: Tkalia, I.G., et al.
Published: (2014)
Detection of breast cancer presenting as a mass in women with dense breasts — digital breast tomosynthesis versus full-field digital mammography
by: Babkina, T.M., et al.
Published: (2023)
by: Babkina, T.M., et al.
Published: (2023)
Investigation of the content of effector cells in peripheral blood of patients with gliomas of different degrees of malignancy
by: L. M. Bielska, et al.
Published: (2018)
by: L. M. Bielska, et al.
Published: (2018)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: Chekhun, S., et al.
Published: (2013)
by: Chekhun, S., et al.
Published: (2013)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: S. Chekhun, et al.
Published: (2013)
by: S. Chekhun, et al.
Published: (2013)
Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018)
by: S. M. Hrybach, et al.
Published: (2018)
Similar Items
-
Features of hepcidin expression in patients with breast cancer
by: Yu. Lukianova, et al.
Published: (2015) -
Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016) -
Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2017) -
Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics
by: V. F. Chekhun, et al.
Published: (2016) -
Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016)